These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17067268)

  • 1. Genotypic variation in the pol gene of HIV type 1 in an antiretroviral treatment-naive population in rural southwestern Uganda.
    Gale CV; Yirrell DL; Campbell E; Van der Paal L; Grosskurth H; Kaleebu P
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):985-92. PubMed ID: 17067268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.
    Becker-Pergola G; Kataaha P; Johnston-Dow L; Fung S; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2000 May; 16(8):807-13. PubMed ID: 10826487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response.
    Ojesina AI; Sankalé JL; Odaibo G; Langevin S; Meloni ST; Sarr AD; Olaleye D; Kanki PJ
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):770-9. PubMed ID: 16910833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
    J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
    J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D.
    Eshleman SH; Gonzales MJ; Becker-Pergola G; Cunningham SC; Guay LA; Jackson JB; Shafer RW
    AIDS Res Hum Retroviruses; 2002 May; 18(7):507-11. PubMed ID: 12015904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa.
    Jacobs GB; Laten A; van Rensburg EJ; Bodem J; Weissbrich B; Rethwilm A; Preiser W; Engelbrecht S
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):1009-12. PubMed ID: 18593350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure.
    Quarleri JF; Rubio A; Carobene M; Turk G; Vignoles M; Harrigan RP; Montaner JS; Salomón H; Gómez-Carrillo M
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1100-7. PubMed ID: 15585101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences.
    Balotta C; Facchi G; Violin M; Van Dooren S; Cozzi-Lepri A; Forbici F; Bertoli A; Riva C; Senese D; Caramello P; Carnevale G; Rizzardini G; Cremonini L; Monno L; Rezza G; Perno CF; Ippolito G; d'Arminio-Monforte A; Vandamme AM; Moroni M;
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):499-505. PubMed ID: 11511828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.
    Zhong P; Kang L; Pan Q; Konings F; Burda S; Ma L; Xue Y; Zheng X; Jin Z; Nyambi P
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):91-101. PubMed ID: 14501800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
    Vergne L; Peeters M; Mpoudi-Ngole E; Bourgeois A; Liegeois F; Toure-Kane C; Mboup S; Mulanga-Kabeya C; Saman E; Jourdan J; Reynes J; Delaporte E
    J Clin Microbiol; 2000 Nov; 38(11):3919-25. PubMed ID: 11060045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes.
    van de Vijver DA; Wensing AM; Angarano G; Asjö B; Balotta C; Boeri E; Camacho R; Chaix ML; Costagliola D; De Luca A; Derdelinckx I; Grossman Z; Hamouda O; Hatzakis A; Hemmer R; Hoepelman A; Horban A; Korn K; Kücherer C; Leitner T; Loveday C; MacRae E; Maljkovic I; de Mendoza C; Meyer L; Nielsen C; Op de Coul EL; Ormaasen V; Paraskevis D; Perrin L; Puchhammer-Stöckl E; Ruiz L; Salminen M; Schmit JC; Schneider F; Schuurman R; Soriano V; Stanczak G; Stanojevic M; Vandamme AM; Van Laethem K; Violin M; Wilbe K; Yerly S; Zazzi M; Boucher CA
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):352-60. PubMed ID: 16540937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
    Balakrishnan P; Kumarasamy N; Kantor R; Solomon S; Vidya S; Mayer KH; Newstein M; Thyagarajan SP; Katzenstein D; Ramratnam B
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):301-5. PubMed ID: 15943572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study.
    Palanisamy N; Osman N; Ohnona F; Xu HT; Brenner B; Mesplède T; Wainberg MA
    AIDS Res Ther; 2017 Jan; 14(1):2. PubMed ID: 28086981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
    Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.